New discoveries in the treatment of AIDS-related cancers.
Prescott
L M
LM
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000276:immunology; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D015497:HIV-1 / Q000187:drug effects*; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy* / Q000276:immunology; D009503:Neutropenia / Q000517:prevention & control; D012514:Sarcoma, Kaposi / Q000188:drug therapy; D014747:Vinblastine / Q000627:therapeutic use; D000077235:Vinorelbine; D019562:Viral Load; D014779:Virus Replication / Q000187:drug effects
D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D016179:Granulocyte Colony-Stimulating Factor; D014747:Vinblastine; D000077235:Vinorelbine